December 20, 2016

59th Annual Scientific Meeting

Home / Events / 59th Annual Scientific Meeting
June 8, 2017 - June 11, 2017
Westin Boston Waterfront, 425 Summer St. Boston, MA 02210

The 59th Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.

Meeting dates

June 8-11, 2017

Meeting location

Westin Boston Waterfront
425 Summer St.
Boston, MA 02210

Faculty

*subject to change

Jessica Ailani, MD, FAHS
Medstar Georgetown University Hospital
Washington, DC, USA

Messoud Ashina, MD, PhD
Danish Headache Center
Glostrup, Denmark

Cenk Ayata, MD
Massachusetts General Hospital / Harvard Medical School
Charlestown, MA, USA

Debora Bevilaqua-Grossi
University of Sao Paulo School of Medicine
Sao Paulo, Brazil

Rami Burstein, PhD
Harvard Medical School / Beth Israel Deaconess Medical Center
Boston, MA, USA

Anne H. Calhoun, MD, FAHS
Carolina Headache Institute
Durham, NC, USA

Yu-Quing Cao, PhD
University of Washington
St. Louis, MO, USA

Andrew C. Charles, MD, FAHS
UCLA Goldberg Migraine Program
Los Angeles, CA, USA

Valeria Contreras
Hospital of Clinics “Dr. Manuel Quintela”
Montevideo, Uruguay

Robert P. Cowan, MD, FAHS
Stanford University
Palo Alto, CA, USA

F. Michael Cutrer, MD
Mayo Clinic
Rochester, MN, USA

Lauren Doyle Strauss, DO
Wake Forest Baptist Health
Winston-Salem, NC, USA

Greg Dussor, PhD
University of Texas at Dallas
Richardson, TX, USA

Michael S. Gold, PhD
University of Pittsburgh
Pittsburgh, PA, USA

Rashmi B. Halker, MD, FAHS
Mayo Clinic
Phoenix, AZ, USA

Andrew D. Hershey, MD, PhD, FAHS
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH, USA

Marielle Kabbouche, MD, FAHS
Cincinnati Children’s Hospital
Cincinnati, OH, USA

Tobias Kurth, MD
Institute of Public Health
Charité – Universitätsmedizin Berlin
Berlin, Germany

Mi Ji Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Seoul, Korea

Elizabeth W. Loder, MD, MPH, FAHS
John R. Graham Headache Center at Faulkner Hospital
Boston, MA, USA

Kenneth J. Mack, MD, PhD, FAHS
Mayo Clinic
Rochester, NY, USA

Michael A. Moskowitz, MD, FAHS
Massachusetts General Hospital
Charlestown, MA, USA

Christopher Oakley, MD
Johns Hopkins University
Baltimore, MD, USA

Jelena M. Pavlovic, MD, PhD
Montefiore Headache Center/Albert Einstein College of Medicine
Bronx, NY, USA

Scott Powers, PhD, ABPP, FAHS
University of Cincinnati College of Medicine and Cincinnati Children’s Hospital
Cincinnati, OH, USA

Marta Liliana Ramos Romero
Hospital Occidente de Kennedy
Bogota, Columbia

Ana Recober, MD, FAHS
Children’s Hospital of Philadelphia
Philadelphia, PA, USA

Noah Rosen, MD, FAHS
North Shore/LIJ Headache Center
Great Neck, NY, USA

Joel R. Saper, MD, FAHS
Michigan Head Pain & Neurological Institute
Ann Arbor, MI, USA

Ann I. Scher, PhD, FAHS
Uniformed Services University of the Health Sciences
Bethesda, MD, USA

Huma Sheikh, MD
Mt. Sinai Beth Israel
New York, NY, USA

Tsubasa Takizawa
Keio University School of Medicine
Tokyo, Japan

Gretchen E. Tietjen, MD
University of Toledo
Toledo, OH, USA

Bert B. Vargas, MD, FAHS
University of Texas Southwestern
Dallas, TX, USA

General Information

SCIENTIFIC PROGRAM COMMITTEE
Chair
Peter J. Goadsby, MD, PhD, FAHS
University of California San Francisco
San Francisco, CA

Members

Jessica Ailani, MD, FAHS
Medstar Georgetown University Hospital
Washington, DC

Rami Burstein, PhD
Harvard Medical School
Waltham, MA

Dawn C. Buse, PhD, FAHS
Albert Einstein College of Medicine
Bronx, NY

Andrew C. Charles, MD, FAHS
University of California Los Angeles
Los Angeles, CA

Amy Gelfand, MD, FAHS
University of California San Francisco
San Francisco, CA

Ana Recober, MD, FAHS
Children’s Hospital of Philadelphia
Philadelphia, PA

Ann I. Scher, PhD, FAHS
Uniformed Services University of the Health Sciences
Bethesda, MD

Todd J. Schwedt, MD, MSCI, FAHS
Mayo Clinic Arizona
Phoenix, AZ

Amaal Starling, MD
Mayo Clinic Arizona
Phoenix, AZ

ABOUT THE AMERICAN HEADACHE SOCIETY®
The American Headache Society® (AHS) is a professional society of healthcare providers dedicated to the study and treatment of headache and face pain. The Society’s objectives are to promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders. Educating physicians, health professionals and the public, and encouraging scientific research are the primary functions of this organization. AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, publication of the journal Headache.

WHO SHOULD ATTEND?
The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.

AHS has dedicated over 59 years to leading and serving the headache community.

THE AMERICAN HEADACHE SOCIETY’S® ANNUAL SCIENTIFIC MEETING continues to be the premiere venue for the dissemination of the latest and most up-to-date research and scientific advances underlying the practice of Headache Medicine.

EDUCATIONAL OBJECTIVES
At the conclusion of this meeting, attendees should be better able to:

• Explain the science behind migraine aura as it impacts clinical practice.
• Identify evolving biomarkers for headache diagnosis.
• Illustrate clinical utility of pediatric headache studies and current approaches to management.
• Recognize emerging therapeutic strategies for the treatment of headache disorders.

EDUCATION MISSION STATEMENT
The provision of quality CME is a primary mission of the American Headache Society®. The Society’s educational objectives are to continue to improve the knowledge, skills, and professional performance of physicians, psychologists, and other health professionals in the care of patients with head, neck, and orofacial pain by:

• Providing a forum for presentation of free scientific communication on research and clinical practice
• Providing educational symposia
• Improving education in medical schools and residency programs
• Identifying and developing new educational initiatives
• Supporting educational programs directed to people with head, neck, and orofacial pain
• Maintaining strict adherence to ACCME guidelines

Developing education activities and tools that are designed and then evaluated for their role in improving the learners’ competence, performance, and the overall quality and safety of the care they give to individuals suffering from head, neck, and

CONTINUING MEDICAL EDUCATION
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. The American Headache Society® takes responsibility for the content, quality, and scientific integrity of this CME activity.

The American Headache Society® designates AMA PRA Category 1 credit(s)™ for the medical education activity, the 59th Annual Scientific Meeting, for a maximum of 19.0 credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

DISCLOSURE STATEMENT
All contributors who can affect American Headache Society CME content (including Leadership, Program Chairs, Moderators, Faculty Members, Medical Writers and Staff), in their respective roles, are required to disclose all relevant financial relationships with any commercial interest that could be viewed as a real or perceived conflict of interest. Contributors will also identify relevant financial relationships of their spouse. This policy is in effect to maintain adherence with the conflict of interest guidelines set by the Accreditation Council for Continuing Medical Education (ACCME) and the American Headache Society Ethics Committee.

Attendees will be made aware of any affiliation or relevant financial interest that may affect the development, management, presentation or evaluation of the CME activity and will be printed in the final program and projected in slide format before each presentation. Individuals who refuse to disclose relevant financial relationships will be disqualified from being a contributor, and cannot have control of, or responsibility for, the development, management, presentation or evaluation of the CME activity.

SPECIAL NOTE FOR THE PHYSICALLY CHALLENGED
The American Headache Society® wishes to take steps to ensure that no individual with disability is excluded, denied services, segregated, or otherwise treated differently than other individuals because of the absence of auxiliary aids and services. If you need any auxiliary aids or services identified in the Americans with Disabilities Act, or any assistance in registering for this symposium, please contact AHS Senior Meeting Manager, Cheryl Gallagher at 856-423-0043, write to her at AHS, 19 Mantua Road, Mt. Royal, NJ, 08061, or email AHSHQ@talley.com.

Program Agenda*

*subject to change

 

Wednesday, June 7, 2017
2:00pm – 6:00pm Women’s Leadership Development Course
Thursday, June 8, 2017
8:00am – 9:00am Committee and Section Meetings
10:00am – 12:30pm Pre-Meeting Courses
Course I: UCNS Course
10:00am – 10:10am Introduction  Noah Rosen, MD, FAHS
10:10am – 10:30am Classification: Migraine and Trigeminal Autonomic Cephalalgias Lauren Doyle Strauss, DO
10:30am – 10:50am Epidemiology, Pathophysiology and Genetics Andrew C. Charles, MD, FAHS
10:50am – 11:15am Abortive and Preventive Pharmacotherapy Jessica Ailani, MD, FAHS
11:15am – 11:40am Neuroimaging Bert B. Vargas, MD, FAHS
11:40am – 12:00pm Secondary Headaches Rashmi B. Halker, MD, FAHS
12:00pm – 12:15pm Additional High Yield Topics and Other Tidbits Noah Rosen, MD, FAHS
12:15pm – 12:30pm Q & A
Course II: Inpatient Treatment for Migraine and Other Severe Headaches – Presented by the AHS Refractory, Inpatient, & Emergency Care and Pediatric & Adolescent Headache Special Interest Sections
10:00am – 10:30am Criteria for Admission: Who is Eligible, Who is Not, and How to Get the Job Done  Joel R. Saper, MD, FAHS
10:30am – 11:15am Case Presentations with Senior Faculty Discussant Discussants: Joel R .Saper, MD, FAHS; Robert Cowan, MD, FAHS; Marielle Kabbouche, MD, FAHS
11:15am – 11:45am In-patient Protocols – Medical, Interventional, and Behavioral  Robert Cowan, MD, FAHS; Marielle Kabbouche, MD, FAHS
11:45am – 12:15pm Life After Admission: Managing Patient Expectation During and After Hospitalization and Discharge Planning Robert Cowan, MD, FAHS
12:15pm – 12:30pm Roundtable Discussion/Q & A  All Faculty
Course III: Should Women with Migraine be Prescribed Hormonal Contraceptives –Presented by the Migraine & Vascular Disease and Women’s Issues Special Interest Sections
10:00am – 10:30am Introduction-Hormonal Contraception: Options and Updates through the Years Huma Sheikh, MD
10:30am – 11:00am Prescribing Hormonal Contraceptives to Women with Migraine – PRO Anne Calhoun, MD
11:00am – 11:30am Prescribing Hormonal Contraceptives to Women with Migraine – CON  Gretchen Tietjen, MD
11:30am – 12:00pm Alternatives to Oral Contraceptives – Case based Discussion Jelena M. Pavlovic, MD, PhD
12:00pm – 12:30pm Q & A
Course IV: What is the Future Holding for Pediatric Headache – Presented by the Pediatric-Adolescent Special Interest Section
10:00am – 10:10am Introduction Marielle Kabbouche, MD, FAHS
10:10am – 10:40am Prevention of Pediatric Headaches: Update and What We Do Now Andrew D. Hershey, MD, PhD, FAHS
10:40am – 11:10am Non-pharmacological Prevention of Headaches: Evidence for Success  Scott W. Powers, PhD, ABPP, FAHS
11:10am – 11:40am Refractory Headaches in Pediatrics, Botox, and Beyond Kenneth J. Mack, MD, PhD, FAHS
 11:40am – 12:10pm Devices and Procedures in Pediatric Headaches Christopher Oakley, MD
 12:10pm – 12:30pm  Q & A
12:30pm – 2:15pm Pan-American/Asian Symposium
12:30pm – 12:35pm Introduction
12:35pm – 12:50pm Demographic and Clinical Profile of Headache in a Low Income Population at Headache Center in Bogota, Columbia Marta Ramos
12:50pm – 12:55pm Q & A
12:55pm – 1:10pm Headache in Emergency Service at Maciel Hospital Valeria Contreras
1:10pm – 1:15pm Q & A
1:15pm – 1:30pm Cervical Dysfunction in Migraine Patients: Are There Differences Between Episodic and Chronic? Debora Bevilaqua-Grossi
 1:30pm – 1:35pm  Q & A
1:35pm – 1:50pm Blood-brain Barrier Breakdown in Reversible Cerebral  Mi Ji Lee
1:50pm – 1:55pm Q & A
1:55pm- 2:10pm Exploring Microglial Change After Cortical Spreading Depression Tsubasa Takizawa
2:10pm – 2:15pm Q & A
12:30pm – 2:15pm Exhibits and Posters
12:30pm – 2:00pm Industry-supported Satellite Symposium: The Science Behind Monoclonal Antibodies: What Headache Specialists Need to Know
2:15pm – 2:30pm Welcome/Opening Remarks R. Allan Purdy, MD, FAHS; Peter J. Goadsby, MD, PhD, FAHS
2:30pm – 2:45pm AMF Presentation David W. Dodick, MD, FAHS
 2:45pm – 5:00pm Symposium in Honor of Michael A. Moskowitz, MD, FAHS – Cortical Spreading Depression and Aura
 2:45pm – 2:50pm Introduction
2:50pm – 3:05pm Where We Were 30 Years Ago and Where We Now in Studying CSD Michael A. Moskowitz, MD, FAHS
 3:05pm – 3:25pm The Last 20 Years of fMRI Work on Aura and What it Taught Us About Migraine F. Michael Cutrer, MD
3:25pm – 3:45pm Spreading Depression and the Cerebral Vasculature Cenk Ayata, MD
3:45pm – 4:00pm Refreshment Break
4:00pm – 4:20pm Vascular Risk of Migraine Aura Tobias Kurth, MD
4:20pm – 4:40pm Preempting Activation and Sensitization of Trigeminovascular Neurons by CSD Rami Burstein, PhD
4:40pm – 5:00pm Q & A
5:00pm – 6:00pm AHS Membership Meeting
6:00pm – 7:30pm Industry Supported Satellite Symposium: A 3-Dimensional View of New and Emerging Treatment Options for Migraine Headaches
Friday, June 9, 2017
6:30am – 8:00am Committee and Section Meetings
6:30am – 8:00am Industry Sponsored Satellite Symposium: Therapeutic Advances and Evolving Treatment Strategies: Novel Approaches to Migraine Management
6:30am – 11:45am Exhibits and Posters with Continental Breakfast
8:00am – 8:45am Seymour Solomon Award Lecture Ann I. Scher, PhD, FAHS
8:45am – 9:00am Lifetime Achievement Award Recipient: Seymour Solomon, MD, FAHS; Presented by: R. Allan Purdy, MD, FAHS
9:00am – 9:15am Video Content Winner Viewing
 Bert B. Vargas, MD, FAHS
9:15am – 9:30am NIH Roadmap for Migraine Research Michael Oshinsky, PhD
9:15am – 10:45am Future of Headache Medicine (Includes IHA Presentations and New Investigator/Trainee Presentations)
10:45am – 11:45am Committee and Section Meetings
10:45am – 11:45am Exhibits and Posters with Refreshments
11:45am – 1:15pm Scientific Paper Presentations – Session 1 (Includes Frontiers in Headache Research Scholarship Presentations)
1:15pm – 2:30pm Exhibits and Poster Session
1:15pm – 2:15pm Industry Supported Product Theater: gammaCore®(non-invasive vagus nerve stimulator): A New Treatment for Cluster Headache
2:30pm – 4:30pm Plenary – Translational Research
2:30pm – 2:35pm Introduction
2:35pm – 2:55pm Meningeal Afferent Signaling and the Pathophysiology of Migraine: Roles of ASIC, BD3F, and Prolactin Greg Dussor, PhD
2:55pm – 3:15pm Modulation of Dural Immune Cells by Stress and the Sympathetic Nervous System Differ by Sex Michael Gold, PhD
 3:15pm – 3:35pm Evaluating Calcium and Potassium Channels Role in Migraine Yuging Cao, PhD
3:35pm – 3:55pm Obesity and the Trigeminal System: Mechanistic Insight into Migraine Progression Ana Recober, MD, FAHS
3:55pm – 4:15pm Are All Migraines Born Equal? Lessons from Triggering Attacks with CGRP, PACAP, PGE2, NO, VIP, Phosphodiestrerase 3 Inhibitor Messoud Ashina, MD, PhD
 4:15pm – 4:30pm Q & A
 4:30pm – 4:45pm Scholarship Award Presentation
 4:45pm – 5:00pm  Break
 5:00pm – 5:45pm Harold G. Wolff Lecture Award
 6:00pm – 7:30pm  Industry-supported Satellite Symposium: BEHIND THEIR EYES: Uncover the Impact of Episodic Migraine on Patients’ Lives
Saturday, June 10, 2017
6:30am – 8:00am Industry Supported Satellite Symposium: Clinically Challenging Concepts in Episodic Migraine: A Case-Based Symposium
6:30am – 10:30am Exhibits and Posters with Continental Breakfast
8:00am – 10:00am Industry-submitted Abstracts (Session not eligible for CME)
10:00am – 10:30am Exhibits and Posters with Refreshments
10:30am – 12:30pm Scientific Paper Presentations Session 2 (Including Late Breaking Abstracts and Frontiers in Headache Research Scholarship Presentations)
12:45pm – 1:45pm Industry-supported Presentation: The Nose-Migraine Nexus
12:30pm – 4:30pm Exhibit Hall Open
2:00pm – 3:30pm Scientific Paper Presentations 3 (Includes Frontiers in Headache Research Scholarship Presentations)
3:30pm – 4:30pm Committee and Section Meetings
 4:30pm – 5:15pm  John R. Graham Lecture Award  Gretchen E. Tietjen, MD
6:00pm – 7:30pm Wine and Cheese Reception
Sunday, June 11, 2017
7:30am – 9:00am Continental Breakfast
9:00am – 11:00pm Plenary: Lessons Learned and Looking to the Future from Recent Clinical Trials
9:00am – 9:02pm Introduction
9:02am – 9:32am CHAMP Trial: Design, Outcomes, Context, and Lessons Learned Andrew D. Hershey, MD, PhD, FAHS
9:32am – 10:07am Cognitive Behavioral Therapy (CBT) for the Treatment of Migraine: Proposed Mechanisms and Future Directions? Scott Powers, PhD, ABPP, FAHS
10:07am – 10:37am Migraine Preventive Clinical Trial Data: Interpretation, Misinterpretation, and Integration into Future Study Designs and Clinical Practice Elizabeth W. Loder, MD, MPH, FAHS
 10:37am – 11:00am Q & A
9:00am – 6:00pm AHMA Patient Conference

Registration

Download the registration brochure.

PLEASE NOTE ONLINE AND ADVANCED REGISTRATION IS NOW CLOSED. You will be able to register onsite starting on Wednesday, June 7, 2017 at 12:00pm.

The following are the AHS Member and Non-Member registration categories and associated fees for the 59th Annual Scientific Meeting.

 

Categories and Fees

 

 

On-site

AHS Member (MD, DO, PhD, DDS)

Non-member (MD, DO, PhD, DDS)

$825.00

$1,000.00

AHS Member Allied Health Professional

Non-member Allied Health Professional

$550.00

$600.00

AHS Member Residents / Trainees

Non-member Residents / Trainees

400.00

$450.00

Active Military Personnel

$400.00

Industry Representative

$1,000.00

Pre-Meeting Course Registration Fees

AHS Member

$250.00

Non-member

$600.00

Registration fees include: admission to all Scientific Sessions, Exhibit Hall, Continental Breakfasts, Refreshments Breaks, and Receptions.

Acceptable Forms of Payment
Checks are acceptable when registration is submitted by mail or completed onsite at the Annual Meeting. Checks must be made payable (in US dollars) to the American Headache Society and issued by a US correspondent bank. The registration is responsible for any and all bank charges.

Credit cards may be used for all registrations. AHS accepted Visa, MasterCard, and American Express. AHS reserves the right to charge the correct amount, if different from your calculated total. Charges will appear on your statement as “AHS Registration”. Note: registrations paid by credit card may be faxed to +856-432-3420. Keep a copy of your fax transmittal confirmation for your record. If faxing, do not mail the original form, doing so may result in duplicate charges to your credit card.

Wire Transfers are accepted provided that the NET AMOUNT of the wire (after bank fees) is sufficient to cover all registration fees in US dollars. Please contact AHS Registration (856-423-0043) for additional information on wire transfer payments.

Cash and Travelers Checks (US dollars only) are accepted for onsite registration at the Annual Meeting. Please do not send cash or travelers checks through the mail.

Group Discounts
AHS encourages you and your colleagues to take advantage of the discounted fees available when two or more from an organization (same location) register for the meeting. Registration for group discounts must be submitted together (by mail or fax) with acceptable form(s) of payment. A discount of $25.00 will be applied after the first registration is charged the full registration amount. The group discount is not available through online registration. Industry representatives are not eligible for the group discount.

Letters of Invitation
If requested, the AHS will send a personal invitation for participation at the Annual Meeting. It should be understood that such an invitation is only to assist participants of the Annual Meeting to raise travel funds and to obtain a VISA and not a commitment on the part of the AHS to provide any financial support.

Cancellation Policy
There will be no refunds after May 31, 2017 deadline.

 

Hotel & Travel

Conference Headquarters Hotel
Transportation
1528_exteriorWESTIN BOSTON WATERFRONT
425 Summer Street
Boston, MA, 02210
T: 617-532-4600
Hotel Reservations: 888-627-7115
www.westinbostonwaterfront.com

The Westin Boston Waterfront is a AAA Four Diamond award-winning hotel and is located in Boston’s thriving Seaport District. The Westin Boston Waterfront is less than three miles from Logan International Airport, and a short cab, bus, water taxi, or T train ride to the historic North End, the Financial District, and scenic Back Bay.

The negotiated conference room rates are as follows:1528_lobby

Single/Double Occupancy Rate: $299.00
Triple Occupancy Rate: $339.00
Quad Occupancy Rate: $379.00

The above rates do not include applicable state and local taxes, currently 14.45%.

wes1528gr-traditional-double-roomRoom reservations will be confirmed on a first come, first served basis until 5:00 pm local hotel time on Thursday, May 4, 2017 or until the block is sold out, whichever comes first. Reservation requests received after the cut-off date noted above will be based on availability at the hotel’s prevailing rate. All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card. Hotel will not hold any reservation unless secured by one of the above methods.

Online reservations can be secured by clicking HERE.

Please note reservations within the AHS block of rooms are for registered attendees ONLY. Reservations made by non-registrants will not receive the discounted rate.

TRANSPORTATIONairplane
Getting to and around Boston

Boston Logan Airport
The Westin Boston Waterfront is only 3.2 miles from New England’s largest transportation hub. Boston Logan Airport has a total of five terminals and is served by all major U.S. and many international airlines.

Boston Logan Airport has four passenger terminals, A, B, C and E, each with its own ticketing, baggage claim, and ground transportation facilities. The terminals are connected to the central parking garage by a walkway system. In all, there are 94 gates with contact jet bridges and nine regional jet gates at the airport and more than 40 airlines fly nonstop to more than 100 domestic and international destinations.

GROUND TRANSPORTATIONbus

Shuttles
Massport provides free shuttle bus service between airline terminals and Airport Station on the MBTA Blueline. All Massport shuttle buses feature low-floors for easier boarding, luggage racks, and are wheelchair lift-equipped.

Buses serving Airport Station and the terminals generally run every 5-6 minutes. Look for the blue-and-white shuttle buses at curbside on the lower level of each terminal.

The Westin Boston Waterfront hotel is located on the MBTA Silver Line at the World Trade Center stop. The Silver Line is accessed via the Red Line at South Station. Once at the World Trade Center stop, proceed 2 levels up to the Mezzanine level. The hotel is located at the end of the foot bridge on Summer Street, next door to the Boston Convention and Exhibition Center.

The MBTA begins daily service Monday – Saturday at 5:35am with the last train arriving at South Station at 1:10am. The schedule varies on Sundays and holidays. Fare costs average between $1.70 – $2.00 per ride.

taxiTaxi Services
Taxis are available at each terminal on Arrivals Level (curbside).

For detailed transportation information to and from Logan Airport, call 1- 800-23-LOGAN.

HOTEL PARKING
Self Parking Rates*
0 to 1 hour $12
1 to 2 hours $21
2 to 3 hours $26
Over 3 to 24 hours $36

Valet Parking Rates*
0 to 1 hour $24
1 to 3 hours $36
Over 3 to 24 hours $46

*As of December 2016-subject to change

Scholarships

Thank you for your interest in our scholarships. Please note the deadline has passed for the 59th Annual Scientific Meeting.

Abstracts

The submission period for Late Breaking Abstracts has ended. Notifications will be sent within the next week to 10 days.

Harold G. Wolff Lecture Award

Thank you for your interest in the Harold G. Wolff Lecture Award. The deadline has passed for 2017.

Exhibits & Sponsorship

The American Headache Society (AHS) is pleased to provide opportunities for exhibits and sponsorship at the 59th Annual Scientific Meeting which will be held June 8-11, 2017 in Boston, MA at the Westin Boston Waterfront Hotel.

To view the available opportunities for sponsorship, as well as view the exhibit floor plan, please click here to download the AHS Exhibit and Sponsorship Prospectus.

Download the Exhibitor Service Manual

Sponsorship Guidelines

Please contact AHS with any questions via email at ahshq@talley.com or call 856-423-0043.

AHS gratefully acknowledges the support of the 59th Annual Scientific Meeting from our industry supporters.

Platinum

 

Allergan

Allergan, Inc.  is a $23 billion diversified global pharmaceutical company and a leader in a new industry model – Growth Pharma. The company is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team creating an unrivaled foundation for long-term growth.

 

Amgen

Amgen, Inc. is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

 

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

 

Lilly

Eli Lilly and Company – Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

 

Teva

Teva Pharmaceuticals is committed to increasing access to high-quality healthcare for people across the globe, at every stage of life. We do this by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.

Gold

Alder

Alder BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms.

Depomed

Depomed, Inc. is a specialty pharmaceutical company focused on products to treat pain and other central nervous system (CNS) conditions.

Silver

Upsher-Smith

Bronze

Avanir

Promius

 

AHS gratefully acknowledges the educational support of the 59th Annual Scientific Meeting from our industry supporters.

Amgen, Inc./Novartis Pharmaceuticals
John R. Graham Headache Center at Brigham and Women’s Faulkner Hospital
Lilly USA
Promius Pharma
Supernus Pharmaceuticals, Inc.
Teva Pharmaceuticals

 

AHS gratefully acknowledges the support of promotional activities for the 59th Annual Scientific Meeting from our industry supporters.

Amgen, Inc./Novartis Pharmaceuticals
Avanir Pharmaceuticals, Inc.
electroCore, LLC
Lilly USA
Supernus Pharmaceuticals, Inc.
Teva Pharmaceuticals
Upsher-Smith Laboratories, Inc.

 

AHS welcomes the Exhibitors to the 59th Annual Scientific Meeting.
Akeso Health Sciences, LLC
Alder BioPharmaceuticals, Inc.
Allergan, Inc.
Allergan Medical Affairs
American Headache Society
American Migraine Foundation
Amgen, Inc./Novartis Pharmaceuticals
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals Medical Information
Avanir Pharmaceuticals Medical Affairs
Avantra Genetics
Cefaly Technology
Dolor Technologies, LLC
electroCore, LLC
eNeura, Inc.
Impax Speciality Pharma
International Headache Society
Lilly USA, LLC
Lilly USA, Inc.
Linpharma
Migraine Research Foundation
National Headache Foundation
NCSG, Inc.
Neurology Reviews
Pernix Therapeutics
Promius Pharma
Supernus Pharmaceuticals, Inc.
TerSera Therapeutics, LLC
Teva CNS
Teva Pharmaceuticals
TheraSpecs
Theranics Bio-Electronics Ltd.
Tian Medical, LLC
Upsher-Smith Laboratories, Inc.
US Pain Foundation, Inc.
Wolters Kluwer

Syllabus

In support of the “Green” community, a printed syllabus will NOT be available for attendees at the Annual Scientific Meeting. The syllabus will be emailed only to registered attendees approximately one week before the meeting begins.

AHS is pleased to provide access to a Meeting App which will be available before the meeting and will be downloadable to your mobile device via the App Store or Google Play. Please check back for more details.

Industry Supported Events

The American Headache Society (AHS)is currently accepting applications for Industry-support Events at the 59th Annual Scientific Meeting at the Westin Boston Waterfront Hotel in Boston, MA.

Please click below to download the appropriate application.  Guidelines and deadlines are included with each application.

Sponsorship Guidelines

Should you have any questions, please do not hesitate to contact AHS via email at ahshq@tallley.com or call 856-423-0043.

Press Room

Press Guidelines
Media Guidelines for Exhibitors, Presenters, Satellite Symposia, and Others

Press Releases

Press Guidelines

General Information

The 59th Annual Scientific Meeting of the American Headache Society (AHS) will be held in Boston from June 8-11, 2017.  The meeting will take place at the Westin Boston Waterfront, 425 Summer Street, Boston, MA 02210. The meeting is a recognized forum for peer-reviewed presentations of new research by headache experts from around the world. As such, it provides an excellent opportunity to present new science, products and technological advancements to the profession. Press Room Location/Hours

The Press Room will be in Elm 1 on the Mezzanine level of the Westin Boston Waterfront. Hours are:

  • Thursday, June 8: 12:00pm-5:00pm
  • Friday, June 9: 8:30am-4:30pm
  • Saturday, June 10: 10:00am-12pm

This space is reserved exclusively as a working area for credentialed media.

Press Passes

Media credentials are reserved exclusively for working members of the editorial media, including print, broadcast or online. To request your press pass please contact Amra Maynard at amra.maynard@inventivhealth.com or 212-845-5625. You will be asked to share a press card, business card or letter of introduction from an editor of a recognized publication, as well as fill out a form that will then need to be emailed to AHSHQ@talley.com.

Upon arrival at the congress, please register at the Congress Registration Desk. Congress registration is located in the Grand Ballroom Foyer, Concourse Level. Registration will be open daily.  Please check hotel and meeting signage for exact time. The Badges should be visible while you are attending the conference.

Embargo Policy

Our embargo policies are strictly enforced. Unless otherwise noted, all data presented at AHS 2017 are embargoed by 12pm on Wednesday, June 7. The AHS reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during the 59th Annual Scientific Meeting.

Webcast

Members of the media are invited to watch the webcast featuring Peter Goadsby MD, PhD, FAHS, Chair of the AHS Scientific Program Committee who will provide AHS 2017 meeting highlights on June 8 at 9 am. To receive additional information and register, please send an email to amra.maynard@inventivhealth.com.

Scheduling Interviews

We will assist you in identifying and interviewing AHS Congress officials, as well as anyone affiliated with the American Migraine Foundation. Please arrange these onsite in the Press Room or in advance by contacting Amra Maynard at amra.maynard@inventivhealth.com or 212-845-5625.

Photography

Non-flash photography is permitted at any of the programs and/or posters presented at the meeting, for non-commercial use. If you are bringing a film crew, please let AHS know in advance. For more information, please contact Amra Maynard at Biosector 2 at 212-845-5625 or amra.maynard@inventivhealth.com.

Media Contact Information

All inquiries should be directed to Amra Maynard at Biosector 2 at 212-845-5625 or amra.maynard@inventivhealth.com.

 

Media Guidelines for Exhibitors, Presenters, Satellite Symposia, and Others

General Information

The 59th Annual Scientific Meeting of the American Headache Society (AHS) will be held in Boston from June 8-11, 2017.  The meeting will take place at the Westin Boston Waterfront, 425 Summer Street, Boston, MA 02210. The meeting is a recognized forum for peer-reviewed presentations of new research by headache experts from around the world.  As such, it provides an excellent opportunity to present new science, products and technological advancements to the profession.

Press Briefings or Other Unaffiliated Events

AHS strictly prohibits any press briefings or any other events not formally affiliated with the AHS annual meeting (e.g., satellite symposia) on any topic related to the research, scientific presentations or content of the Annual Scientific Meeting at Westin Boston Waterfront, or other locations at any time during the dates and hours of the meeting.

Embargo Policy

Our embargo policies are strictly enforced. Unless otherwise noted, all data presented at the Annual Scientific Meeting are embargoed by 12pm on Wednesday, June 7. The AHS reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during the 59th Annual Scientific Meeting.

Press Room

The Press Room will be located in Elm 1 room on the Mezzanine level of the Westin Boston Waterfront. Hours are

  • Thursday, June 8: 12:00pm-5:00pm
  • Friday, June 9: 8:30am-4:30pm
  • Saturday, June 10: 10:00am-12pm

This space is reserved exclusively as a working area for credentialed media. Individuals are not allowed in the Press Room unless they have been invited for an interview and are meeting with a registered reporter with clearly identifiable press pass. Exhibitors cannot register as press. 

The Press Room will have a table for copies of exhibitor, presenter and attendee press materials. For your press materials to be included, you must submit them for review by May 22 to:

Once approved, please leave print copies of the approved materials with the Press Room staffer.

Leftover media materials must be retrieved from the Press Room by 12pm Saturday, June 10, or they will be discarded.

Photo/Video Policy
Filming and photography of the AHS Annual meeting proceedings and presentations, as well as any related visual materials, is allowed on a case-by-case basis.

Please check with Cheryl Gallagher at 856-423-7222 or cgallagher@talley.com.

 Questions?

All questions should be directed to Cheryl Gallagher at 856-423-7222 or cgallagher@talley.com.

For media-related questions, please reach out to Amra Maynard at Biosector 2 at 212-845-5625 or amra.maynard@inventivhealth.com.

Related events